Sign in Pull a receipt

SLS

SELLAS Life Sciences Group, Inc.

Healthcare · Biotechnology

$82.80 sample

-0.69 (-0.83%) 1D

Market cap

$510.9B

Price as of

2026-10-29

Latest filing

8-K

Alerts

8

Price$82.80 +13.39% 3M daily closessample

86.8070.94

2026-08-032026-08-252026-09-162026-10-072026-10-29

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 26INSInsider buy: Chief Financial Officer
Oct 20INSInsider buy: EVP, Operations
Oct 15INSInsider sell: EVP, Operations
Oct 07INSInsider sell: Director
Oct 02INSInsider sell: 10% owner
Sep 23INSInsider sell: General Counsel
Sep 17INSInsider buy: 10% owner
Sep 08INSInsider buy: General Counsel

Sign up to see the real SLS record →

Company facts

SEC EDGAR registration

Name: SELLAS Life Sciences Group, Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: +18sample, -100 to +100
Reporting currency: USD

Who is positioning in SLS

sample

Insiders: 15 insider transactions over 90 days, net selling, $158.9M
Congress: 1 members traded over 90 days
Institutions · 13F: 36 funds hold $7.0B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$16.7B +15.0% y/y

Q4 2024Q3 2026

Inventory$10.5B +15.8% y/y

Q4 2024Q3 2026

Accounts receivable$7.3B +8.2% y/y

Q4 2024Q3 2026

Total debt$21.0B +11.6% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $399.7B -9.3% 3M
Sample peer B: $277.2B -3.8% 3M
Sample peer C: $452.2B -6.0% 3M
Sample peer D: $322.2B -9.4% 3M
Sample peer E: $333.0B -11.9% 3M